Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 June 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hepatitis A virus link to atopic disease

A declining prevalence of hepatitis A virus infection may contribute to an increase in atopic disease, find researchers in this week's issue of Nature.

News image

fiogf49gjkf04

Atopic diseases, such as asthma, allergic rhinitis and dermatitis, are caused by a combination of environmental and genetic factors.

Exposure to HAV is associated with poor hygiene, large family size and attendance at day-care centers. These are all factors which are inversely associated with atopy.

In this study, researchers from the United States determined that that infection by hepatitis A virus (HAV) may protect individuals from atopy.

Infection with HAV may have protected many individuals against atopy.
Nature

The research team identified TIM-1 as a candidate gene for atopy and asthma in a region of mouse chromosome 11. This is homologous to a segment of human chromosome 5q31–33 that has been linked to atopy.

The team investigated whether the interaction between HAV and TIM-1 on lymphocytes can modify T cells in a way that protects against atopy. They also examined whether polymorphisms in TIM-1 can alter susceptibility to atopy.

The researchers identified a 6-amino-acid insertion at residue 157 (157insMTTTVP) and 2 single-amino-acid changes. To determine the effect of 157insMTTTVP on the occurrence of atopy, the team evaluated 375 individuals who were tested for atopy and prior HAV infection.

The research team found that HAV seropositivity protects against atopy. However, this protection only occurs in individuals with the 157insMTTTVP variant of TIM-1.

Prior to 1970, the seroprevalence of antibodies against HAV approached 100% in Western countries. Therefore infection with HAV may have protected many individuals against atopy.

However, reduction in family size and improved public health has caused anti-HAV seroprevalence to fall to between 25 and 30%, while the prevalence of atopic disease has doubled.

The interaction between HAV and TIM-1 genotype may contribute to the etiology of atopic diseases, and provide a mechanism to account for the hygiene hypothesis.

Dr Jennifer McIntire's team concluded, "Our finding…indicates that exposure to a specific pathogen may influence the expression of atopy".

"A declining prevalence of HAV infection could contribute to an increase in atopy by association with TIM-1".

"It will be necessary to determine whether HAV exposure must occur during childhood to have a protective effect".

Also, "Whether HAV can mitigate the severity of existing atopic disease, and whether HAV vaccination can reproduce the effects of natural HAV infection".

Nature 2003; 425: 576
13 October 2003

Go to top of page Email this page Email this page to a colleague

 31 May 2018 
Diagnostic for NAFLD  
 31 May 2018 
Bile acids and the risks for hepatotoxicity
 31 May 2018 
Rectal cancer female sexuality score
 30 May 2018 
Fungal dysbiosis in cirrhosis
 30 May 2018 
Placebo rates in ulcerative colitis trials
 30 May 2018 
Follow-up testing and colorectal cancer mortality
 29 May 2018 
Organ transplantation donors
 29 May 2018 
Novel therapies for IBD
 29 May 2018 
Helicobacter pylori infection to stomach cancer
 28 May 2018 
Mesalazine in ulcerative colitis
 28 May 2018 
Technology and management of digestive diseases
 28 May 2018 
Therapeutic strategies for HCV
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Chronic Hep B
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
European guidelines on pancreatic cystic neoplasms

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us